A row over coronavirus vaccine shortages in the EU has descended into farce as AstraZeneca denied claims by the European commission that it had pulled out of a crunch meeting over a breakdown in supplies.
Within minutes of a spokeswoman for the commission announcing that the Anglo-Swedish pharmaceutical company was refusing to attend, the claim was rebutted in a short statement. “We can confirm we have not pulled out and will be attending talks with the EU commission later today,” a spokesman for AstraZeneca said.
Related: EU’s vaccine supply issues mean light at end of tunnel that much further away